Dr. Richard Enoch Kaufman, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 960 Main St, Branford, CT 06405 Phone: 203-488-6358 Fax: 203-481-5327 |
News Archive
An experimental drug, LX211 (LUVENIQ-; oral voclosporin), may become the first approved oral treatment capable of modifying the course of uveitis, a group of serious eye conditions inevitably associated with either severe vision loss or substantial morbidity from steroid use.
The New York Stem Cell Foundation announced today that Franziska Michor, PhD, is the 2015 recipient of the NYSCF - Robertson Stem Cell Prize for her work pioneering new approaches to study the growth, spread, and treatment of cancer. Her laboratory fuses her passions in mathematics, molecular biology and patient care to investigate how cancers form and progress.
Nearly half of all atrial fibrillation (AF) patients at the highest risk for stroke are not being prescribed blood thinners by their cardiologists, according to a new study by researchers at University of California, San Diego School of Medicine and University of California, San Francisco.
Neuroimaging measures of emotional brain function after acute trauma may help predict whether a person will develop posttraumatic stress disorder (PTSD), according to a new study in Biological Psychiatry.
With mounting concerns over childhood obesity and its associated health risks in the U.S., would a ban on junk-food advertising aimed at children be more effective than the current voluntary, industry-led ban? According to published research from a University of Illinois economist, advertising bans do work, but an outright ban covering the entire U.S. media market would be the most effective policy tool for reducing fast-food consumption in children.
› Verified 7 days ago